Literature DB >> 24090367

Laparoendoscopic single-site surgery using innovative articulating instruments: preclinical evaluation of the prototype.

Jin-Woo Jung1, Woo Heon Cha, Byung Ki Lee, Sangchul Lee, Seung Bae Lee, Sang Eun Lee, Chang Wook Jeong.   

Abstract

Conventional articulating instruments for laparoendoscopic single-site (LESS) surgery have three major drawbacks: Weak articulating force, internal and external crowding, and mirror imaging and motion. The RoboHand™ is a recently developed novel articulating instrument. The goal of its development was to minimize the abovementioned three major drawbacks. In an ex vivo test, the joint force of the RoboHand was 2.5 to 3 times stronger than that of the LaparoAngle™ or the SILS™ instrument. In the porcine nephrectomy model, the operative times in the RoboHand group (28.8±6.6 min) were shorter than those in the LaparoAngle group (39.7±5.4 min), although not significant (P=0.146). The RoboHand prototype seems to be superior to other articulating laparoscopic instruments in its mechanical properties, such as joint force, and not to be clinically inferior to LaparoAngle for LESS. We describe the techniques for using this innovative instrument and discuss its advantages.

Mesh:

Year:  2013        PMID: 24090367     DOI: 10.1089/end.2013.0510

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  2 in total

1.  Single-site laparoscopic appendectomy in children using conventional instruments: a prospective, randomized, control trial.

Authors:  Kai Wu; Liucheng Yang; Aiguo Wu; Jianjun Wang; Shuai Xu; Haijun Zhao; Zonghai Huang
Journal:  Pediatr Surg Int       Date:  2014-11-09       Impact factor: 1.827

2.  Animal model evaluation of a novel renal denervation system for future laparoscopic treatment of resistant hypertension.

Authors:  Won Hoon Song; Jinhwan Baik; Sunchoel Yang; Eue-Keun Choi; Sung-Min Park; Chang Wook Jeong
Journal:  Investig Clin Urol       Date:  2019-12-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.